Skip to main content

Year: 2026

Laureate Education Reports Financial Results for the First Quarter of 2026

Company Increases Full-Year 2026 Adjusted Earnings Per Share Guidance MIAMI, April 30, 2026 (GLOBE NEWSWIRE) — Laureate Education, Inc. (NASDAQ: LAUR), which operates five higher education institutions across Mexico and Peru, today announced financial results for the first quarter of 2026. First Quarter 2026 Highlights (compared to first quarter 2025):New enrollments increased 9%. Total enrollments increased 6%. On a reported basis, revenue increased 15% to $272.6 million. On a constant currency basis1, revenue increased 1% and was unfavorably affected by approximately $9 million of intra-year academic calendar timing attributable to later semester start dates in the first quarter of 2026 as compared to the first quarter of 2025. Operating loss for the first quarter of 2026 was $(27.5) million, compared to an operating loss of...

Continue reading

Hubbell Reports First Quarter 2026 Results

Shelton, CT, April 30, 2026 (GLOBE NEWSWIRE) — HUBBELL REPORTS FIRST QUARTER 2026 RESULTS Q1 diluted EPS of $3.41; adjusted diluted EPS of $3.93 (up 16% y/y) Q1 net sales 11% (organic 8.2%; foreign exchange 0.6%; M&A 2.3%) Q1 operating margin 17.4%; adjusted operating margin 19.8% (up 110 bps y/y) Raising FY 2026 diluted EPS expected range to $17.45-$18.00; adj. diluted EPS of $19.30-$19.85SHELTON, CT. (April 30, 2026) – Hubbell Incorporated (NYSE: HUBB) today reported operating results for the first quarter ended March 31, 2026. “Hubbell delivered strong performance in the first quarter, with double digit growth in sales, operating profit and earnings per share” said Gerben Bakker, Chairman, President and CEO. Mr. Bakker continued, “Organic sales growth of 8% in the first quarter was driven by double...

Continue reading

FTAI Infrastructure Inc. Announces Agreement to Sell Long Ridge Energy and Power to MARA Holdings, Inc.

MARA to purchase Long Ridge for total transaction value of approximately $1.52 billion FIP plans to use net proceeds to repay corporate debt and reinvest in growth opportunities Transaction expected to close in the third quarter of 2026 following receipt of necessary regulatory approvals NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) — FTAI Infrastructure Inc. (NASDAQ:FIP; the “Company” or “FIP”) announced today that it has entered into a definitive agreement to sell Long Ridge Energy & Power LLC (“Long Ridge”) and certain related assets to a subsidiary of MARA Holdings, Inc. (NASDAQ: MARA). The transaction is valued at approximately $1.52 billion before closing adjustments. Headquartered in Pittsburgh, Pennsylvania, Long Ridge is a vertically integrated power and gas company comprised of a highly efficient, 485-megawatt...

Continue reading

Aurora Spine Corporation Announces Record Fourth Quarter and FY25 Financial Results

– Q4 revenue surpasses $5 million threshold – –Company to host conference call today, April 30th  at 11am ET/8am PT – NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., April 30, 2026 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in the development of groundbreaking medical devices for spinal surgery, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2025. All figures are in U.S. dollars. Financial and Business HighlightsFirst $5 million quarter – Q4 2025 sales were $5,022,865 compared to $4,430,755 in Q3 2025 and $4,702,317 in Q4 2024.Strong improvements in EBITDAC – EBITDAC for FY2025 was $587,532 compared to $282,450 in 2024, an improvement of 108% or $305,082. EBITDAC...

Continue reading

uniQure Announces Successful UK MHRA Pre-Submission Meeting for AMT-130 in Huntington’s Disease

~ Submission of a UK Marketing Authorization Application for AMT-130 is expected in the third quarter of 2026 ~ ~ Type B Meeting with U.S. FDA granted in second quarter; expect to discuss potential Phase III design and analysis plan for AMT-130 four-year data ~ ~ uniQure actively pursuing additional ex-US regulatory pathways to support potential registration of AMT-130 in international markets ~ LEXINGTON, Mass. and AMSTERDAM, April 30, 2026 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the Company held a Pre-Submission Meeting with the United Kingdom’s (UK) Medicines and Healthcare products Regulatory Agency (MHRA) and plans to submit a Marketing Authorization Application (MAA) for AMT-130 for the treatment...

Continue reading

Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2026

BANNOCKBURN, Ill., April 30, 2026 (GLOBE NEWSWIRE) — Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Highlights(year-over-year comparisons unless otherwise noted)Net revenue of $1,350.7 million, up 1.3% GAAP Net income of $45.3 million, down 3.0% GAAP diluted earnings per share of $0.29, up 3.6% Adjusted EBITDA of $104.8 million, down 6.3% Adjusted diluted earnings per share of $0.40, flat to the first quarter of 2025 Cash used in operating activities of $12.1 million Repurchased $17.5 million of stock in the quarter Revolving credit facility expanded from $400 million to $850 million“The first quarter...

Continue reading

AC Immune First Quarter 2026 Financial and Corporate Updates

AC Immune First Quarter 2026 Financial and Corporate UpdatesDosed first subjects in Phase 1 trial of brain-penetrant small molecule NLRP3 inhibitor ACI-19764 with SAD/MAD results in healthy volunteers expected in H2 2026 Initiated final cohort, AD4, in ABATE Phase 1b/2 trial of ACI-24 to treat Alzheimer’s Disease triggers milestone payment, as announced separately todayAmended Morphomer® Tau collaboration with Lilly reflects growing excitement for targeting intracellular Tau and significant progress with our Morphomer® small molecules Approaching multiple milestones including 12-month interim results of the AD3 cohort in ABATE in Q2 2026 and full data from Part 1 of ACI-7104 VacSYn Phase 2 trial expected in H2 2026 Cash resources of CHF 74.8 million as of March 31, 2026, provide funding into Q4 2027Lausanne, Switzerland,...

Continue reading

LKQ Corporation Announces Results for First Quarter 2026

Board of Directors Initiated a Comprehensive Review of Strategic Alternatives to Enhance Shareholder Value Maintains Focus on Returning Capital to Shareholders with $77 million in Cash Dividends to Shareholders Dividend of $0.30 Per Share Approved to be Paid in Second Quarter of 2026 ANTIOCH, Tenn., April 30, 2026 (GLOBE NEWSWIRE) — LKQ Corporation (Nasdaq: LKQ) today reported first quarter 2026 financial results. “We are operating in a challenging environment and are focused on improving our results. Our teams are taking deliberate actions to reduce costs, streamline operations while taking market share, and position ourselves for success going forward as the environment improves. In North America, our business held up well in the quarter with above market growth, and we’re starting to see signs of recovery in the market. In Europe,...

Continue reading

OTC Markets Group Welcomes Charlotte’s Web Holdings Inc. to OTCQX

NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Charlotte’s Web Holdings Inc. (TSX: CWEB; OTCQX: CWBHF), a botanical wellness innovation company, has qualified to trade on the OTCQX® Best Market. Charlotte’s Web Holdings Inc. upgraded to OTCQX from the OTCQB® Venture Market. Charlotte’s Web Holdings Inc. begins trading today on OTCQX under the symbol “CWBHF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. The OTCQX Market is designed for established, investor-focused U.S. and international companies. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance,...

Continue reading

Loblaws Serves Up Pairings for Every Emotion with new “FOODS FOR ALL THE MOODS” Platform, Featuring Antoni Porowski

This multi-channel platform meets Canadians everywhere on the spectrum of emotions, feelings and moods BRAMPTON, Ontario, April 30, 2026 (GLOBE NEWSWIRE) — Prepare to satisfy every craving and comfort every emotion! Loblaws®, Zehrs®, and Your Independent Grocer® are thrilled to unveil their new multi-channel “FOODS FOR ALL THE MOODS” brand platform this spring. This platform and campaign are a rich and vibrant celebration of life’s moments, big and small, demonstrating how our trusted stores and colleagues consistently provide the perfect food solutions for every mood and occasion. Joining this exciting journey is the beloved culinary expert and television personality, Antoni Porowski, making a fun and engaging return. “We know that food plays a spectrum of different roles in people’s lives. It has the incredible power...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.